About the Authors
- Datsen George Wei
-
Affiliation Gilead Sciences, Foster City, California, United States of America
- Vicki Chiang
-
Affiliation Gilead Sciences, Foster City, California, United States of America
- Elizabeth Fyne
-
Affiliation Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America
- Mini Balakrishnan
-
Affiliation Gilead Sciences, Foster City, California, United States of America
- Tiffany Barnes
-
Affiliation Gilead Sciences, Foster City, California, United States of America
- Michael Graupe
-
Affiliation Gilead Sciences, Foster City, California, United States of America
- Joseph Hesselgesser
-
Affiliation Gilead Sciences, Foster City, California, United States of America
- Alivelu Irrinki
-
Affiliation Gilead Sciences, Foster City, California, United States of America
- Jeffrey P. Murry
-
Affiliation Gilead Sciences, Foster City, California, United States of America
- George Stepan
-
Affiliation Gilead Sciences, Foster City, California, United States of America
- Kirsten M. Stray
-
Affiliation Gilead Sciences, Foster City, California, United States of America
- Angela Tsai
-
Affiliation Gilead Sciences, Foster City, California, United States of America
- Helen Yu
-
Affiliation Gilead Sciences, Foster City, California, United States of America
- Jonathan Spindler
-
Affiliation HIV Drug Resistance Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America
- Mary Kearney
-
Affiliation HIV Drug Resistance Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America
- Celsa A. Spina
-
Affiliation Department of Pathology, School of Medicine, University of California San Diego, La Jolla, California, United States of America
- Deborah McMahon
-
Affiliation Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America
- Jacob Lalezari
-
Affiliation Quest Clinical Research, San Francisco, California, United States of America
- Derek Sloan
-
Affiliation Gilead Sciences, Foster City, California, United States of America
- John Mellors
-
Affiliation Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America
- Romas Geleziunas
-
Affiliation Gilead Sciences, Foster City, California, United States of America
- Tomas Cihlar
-
* E-mail: tomas.cihlar@gilead.com
Affiliation Gilead Sciences, Foster City, California, United States of America
Competing Interests
DGW, VC, MB, TB, MG, JH, AI, JPM, GS, KMS, AT, HY, DS, RG, and TC are employees of Gilead Sciences, Inc. JM is a scientific advisor of Gilead Sciences, Inc. JL is a director of Quest Clinical Research that provided clinical specimens. EF, JS, MK, CAS, and DM have no competing interests. Part of the study was funded by Gilead Sciences, Inc. Employees of the company were involved in study design, data collection and analysis, and writing the manuscript. However, none of the therapeutics characterized in this study are products of Gilead Sciences, and studies were designed, executed, and objectively interpreted purely with a purpose to advance basic research in the field of HIV latency and cure. This does not alter our adherence to all PLOS Pathogens policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: DGW VC EF MB TB JH GS AT HY DS JM RG TC. Performed the experiments: DGW VC EF MB TB JH AI JPM GS AT HY DS JS. Analyzed the data: DGW VC EF MB JH AI JPM GS AT HY DS JM RG TC MK JS. Contributed reagents/materials/analysis tools: TB MG KMS CAS DM JL. Wrote the paper: DGW DS JM RG TC.